NCT03280667 2023-03-29
KEYPAD
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Unknown
Clinical Trials
11 trialsNCT05435768 2022-08-18
PRaG 2X
Second Affiliated Hospital of Soochow University
Unknown
NCT03161756 2022-04-07
CHARLI
Melanoma and Skin Cancer Trials Limited
Phase 1/2 Unknown
NCT03732495 2022-03-29
LENVOS
Centre Leon Berard
Phase 2 Unknown
NCT04859569 2021-06-07
Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors
Luye Pharma Group Ltd.
Phase 3 Unknown
NCT04550949 2020-09-22
To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT04494373 2020-08-04
Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT03605199 2019-08-26
Denosumab in Subjects With Giant Cell Rich Tumors of Bone
Leiden University Medical Center
Phase 2 Unknown
NCT03811509 2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4 Unknown
NCT03358212 2017-11-30
Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China
Peking University People's Hospital
Unknown
NCT03259152 2017-08-24
D-Gct
Hebei Medical University Third Hospital
Phase 3 Unknown